For example, intraocular anti-VEGF agents are used to treat a number of retinal diseases including macular degeneration, diabetic retinopathy, and retinal vascular occlusions with some patients receiving, and tolerating well, monthly injections for years [47]. This evidence concerns the gene VEGFA and retinal vein occlusion.